Antithrombin 'DREUX' (Lys114Glu): A variant with complete loss of heparin affinity

Thrombosis and Haemostasis

Volumn 88, Issue 3, 2002, Pages 436-443

  Mushunje, Alec ^a   Zhou, Aiwu ^a   Huntington, James A ^a   Conard, Jacqueline ^a   Carrell, Robin W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antithrombin; Heparin; Mutant; Serpin; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A; GLUTAMIC ACID; GLYCOSAMINOGLYCAN; HEPARIN; LYSINE; PENTASACCHARIDE; SERINE PROTEINASE INHIBITOR; TICLOPIDINE; ANTITHROMBIN III;

ADULT; ANAMNESIS; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN ISCHEMIA; CASE REPORT; CHROMOSOME VARIANT; DISEASE ASSOCIATION; EXON; FATHER; FLUORESCENCE ANALYSIS; GENE ACTIVATION; GENE MUTATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INHIBITION KINETICS; MALE; MUTANT; PRIORITY JOURNAL; PROTEIN BINDING; THERMAL ANALYSIS; THROMBOSIS; ANIMAL; BLOOD; CATTLE; CHEMISTRY; DRUG ANTAGONISM; FAMILY HEALTH; GENETIC VARIABILITY; GENETICS; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE;

ANIMALS; ANTITHROMBIN III; BINDING SITES; BRAIN ISCHEMIA; CATTLE; DNA MUTATIONAL ANALYSIS; FACTOR XA; FAMILY HEALTH; HEPARIN; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MUTATION, MISSENSE; PROTEIN BINDING; VARIATION (GENETICS);

EID: 0036712294     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613235     Document Type: Article

References (30)

1. Serpins: Antithrombin and other inhibitors of coagulation. Evidence from amino acid sequences
2. 1-antitrypsin for structure and function of serpins
3. Identification of a lysyl residue in antithrombin which is essential for heparin binding
4. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine
5. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser
6. Homozygous antithrombin deficiency: Report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis
7. Antithrombin III Nagasaki (Ser116-Pro): A heterozygous variant with defective heparin binding associated with thrombosis
8. The anticoagulant activation of antithrombin by heparin
9. Biological implications of a 3Å structure of dimeric antithrombin
10. Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation
11. Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding
12. Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
13. Further characterization of the antithrombin-binding sequence in heparin
14. Chemical synthesis of heparin fragments and analogues
15. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH)
16. Antifactor Xa activity measured with amidolytic methods
17. Investigations on antithrombin III in normal plasma and serum
18. Five antithrombin variants, four associated with thrombosis
19. Antithrombin and its inherited deficiencies
20. A simple two-step procedure for the isolation of antithrombin III from biological fluids
21. The size and shape of human and bovine antithrombin III
22. Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancement
23. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin
24. Mechanisms of heparin activation of antithrombin: Evidence for an induced-fit model of allosteric activation involving two interaction subsites
25. Engineering plasminogen activator inhibitor 1 mutants with increased functional stability
26. Antithrombins wibble and wobble (T85M/K): Archetypal conformational diseases with in vivo latent-transition, thrombosis and heparin activation
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. Formation of the antithrombin heterodimer and the onset of thrombosis
29. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin
30. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis